Graf M W, Uhr J W
J Exp Med. 1969 Nov 1;130(5):1175-86. doi: 10.1084/jem.130.5.1175.
Rabbits were injected intravenously with bovine serum albumin (BSA) and bacteriophage T(2) (T(2)). 2-3 wk later, anti-BSA was removed from such animals by a procedure which involved exposure of removed plasma to an immunoadsorbent ((125)I-BSA bound to bromoacetyl cellulose) and return of the adsorbed plasma to the animal. This resulted in removal of the majority of antibody activity to BSA without affecting antibody levels to T(2). 1-2 days later, anti-BSA levels began to rise, and reached peak levels usually 5 days after the removal of antibody. Antibody levels to T(2) did not change. No evidence was obtained that BSA was released from the immunoadsorbent into the circulation of the rabbits. Thus, only trace amounts of radioactivity were released into the plasma; most of the radioactivity was equally coprecipitable with BSA or human gamma globulin and their specific antibodies; the released material was not demonstrated to be immunogenic in primed rabbits; and the released material did not elute with BSA on gel filtration. The results are interpreted as evidence that serum antibody acts as a regulatory mechanism for antibody formation during the conventional antibody response to a metabolizable antigen.
给兔子静脉注射牛血清白蛋白(BSA)和噬菌体T(2)(T(2))。2 - 3周后,通过一种程序从这些动物体内去除抗BSA,该程序包括将去除的血浆暴露于免疫吸附剂(与溴乙酰纤维素结合的(125)I - BSA),然后将吸附后的血浆回输到动物体内。这导致去除了大部分针对BSA的抗体活性,而不影响针对T(2)的抗体水平。1 - 2天后,抗BSA水平开始上升,通常在去除抗体后5天达到峰值水平。针对T(2)的抗体水平没有变化。没有证据表明BSA从免疫吸附剂释放到兔子的循环系统中。因此,只有微量放射性物质释放到血浆中;大部分放射性物质与BSA或人γ球蛋白及其特异性抗体共沉淀;释放的物质在致敏兔子中未显示具有免疫原性;并且释放的物质在凝胶过滤时不会与BSA一起洗脱。这些结果被解释为血清抗体在对可代谢抗原的常规抗体反应过程中作为抗体形成的调节机制的证据。